Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -40.13% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -43.16%. Over the past 30 days, the price of RIGL has leaped by -1.75%. And in the last five days, it has surged by 9.79%.
The stock of Rigel Pharmaceuticals (RIGL) is currently priced at $0.90. In the last session, the stock climbed significantly, topping out at $0.9001 after opening at $0.8102. The day’s lowest price was $0.7885 before the stock closed at $0.81.
Rigel Pharmaceuticals experienced a rather steady stock market performance. The highest value in the past year was recorded at $2.04 on 01/23/23 and the lowest value was $0.67 on 12/01/22.
52-week price history of RIGL Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Rigel Pharmaceuticals’s current trading price is -55.98% away from its 52-week high, while its distance from the 52-week low is 34.03%. The stock’s price range during this period has varied between$0.67 and $2.04. The Rigel Pharmaceuticals’s shares, which operate in the Healthcare, saw a trading volume of around 0.85 million for the day, a figure considerably lower than their average daily volume of 1.0 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Rigel Pharmaceuticals (RIGL) has experienced a quarterly decline of -25.79% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 156.58M and boasts a workforce of 155 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0935, with a change in price of -0.4820. Similarly, Rigel Pharmaceuticals recorded 1,068,551 in trading volume during the last 100 days, posting a change of -34.93%.
RIGL Stock Stochastic Average
As of today, Rigel Pharmaceuticals’s raw stochastic average for the last 50 days stands at 39.74%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 94.03%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 56.99% and 45.68%, respectively.